Optimization Compounds. Optimization Compounds, their structures and best methods of synthesis and manufacture developed during the Optimization Program shall be made available only to ICOS for research or application to any Optimization Target, within or outside the Collaboration, during the Optimization Period, and Array shall not work on or provide information regarding such Optimization Compound to any Third Party, except to take any steps necessary to protect ICOS's exclusivity hereunder.
Appears in 3 contracts
Sources: Lead Optimization Agreement (Array Biopharma Inc), Drug Discovery Collaboration Agreement (Array Biopharma Inc), Drug Discovery Collaboration Agreement (Array Biopharma Inc)